Celldex Therapeutics Inc. (TCE2)
Market Closed
24 Feb, 20:00
XSTU 
€
21. 20
+0.8
+3.92%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-3.01 Eps
€ 20.4
Previous Close Day Range
20.4 21.2
Year Range
13.3 25.4
Want to track TCE2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TCE2 earnings report is expected in 1 days (26 Feb 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
TCE2 Earnings Reports FAQ
What is the earnings per share (EPS) for TCE2?
The current EPS is -3.01.
What is the company's earnings growth rate?
Celldex Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-26, based on the TCE2's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Celldex Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TCE2 at this time, as Celldex Therapeutics Inc has no recent EPS data to calculate it.
